Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia

Article metrics

Abstract

Aberrant activation of β-catenin promotes cell proliferation1 and initiates colorectal tumorigenesis2,3. However, the expansion of tumours and the inadequacy of their local vasculature results in areas of hypoxia where cell growth is typically constrained4,5. Here, we report a novel diversion in β-catenin signalling triggered by hypoxia. We show that hypoxia inhibits β-catenin–T-cell factor-4 (TCF-4) complex formation and transcriptional activity, resulting in a G1 arrest that involves the c-Myc–p21 axis. Additionally, we find that hypoxia inducible factor-1α (HIF-1α) competes with TCF-4 for direct binding to β-catenin. DNA–protein interaction studies reveal that β-catenin–HIF-1α interaction occurs at the promoter region of HIF-1 target genes. Furthermore, rigorous analyses indicate that β-catenin can enhance HIF-1-mediated transcription, thereby promoting cell survival and adaptation to hypoxia. These findings demonstrate a dynamic role for β-catenin in colorectal tumorigenesis, where a functional switch is instigated to meet the ever-changing needs of the tumour. This study highlights the importance of the microenvironment in transcriptional regulation.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Inhibition of β-catenin–TCF-4 transcriptional activity and induction of a cell-cycle arrest during hypoxia.
Figure 2: Interaction between β-catenin and HIF-1α.
Figure 3: Mapping the interaction between HIF-1α and β-catenin.
Figure 4: Functional significance of HIF-1α–β-catenin interaction.
Figure 5: Enhancement of HIF-1 transcriptional activity and cell survival by β-catenin in colon cancer cells.

References

  1. 1

    van de Wetering, M. et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241–250 (2002).

  2. 2

    Korinek, V. et al. Constitutive transcriptional activation by a β-catenin–Tcf complex in APC−/− colon carcinoma. Science 275, 1784–1787 (1997).

  3. 3

    Morin, P. J. et al. Activation of β-catenin–Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275, 1787–1790 (1997).

  4. 4

    Carmeliet, P. et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485–490 (1998).

  5. 5

    Harris, A. L. Hypoxia — a key regulatory factor in tumour growth. Nature Rev. Cancer 2, 38–47 (2002).

  6. 6

    Reya, T. & Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843–850 (2005).

  7. 7

    van de Wetering, M. et al. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88, 789–799 (1997).

  8. 8

    He, T. C. et al. Identification of c-MYC as a target of the APC pathway. Science 281, 1509–1512 (1998).

  9. 9

    Hockel, M. & Vaupel, P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl Cancer Inst. 93, 266–276 (2001).

  10. 10

    Maxwell, P. H. et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl Acad. Sci. USA 94, 8104–8109 (1997).

  11. 11

    Wang, G. L., Jiang, B. H., Rue, E. A. & Semenza, G. L. Hypoxia-inducible factor-1 is a basic-Helix-Loop-Helix-PAS heterodimer regulated by cellular O2 Tension. Proc. Natl Acad. Sci. USA 92, 5510–5514 (1995).

  12. 12

    Semenza, G. L. Targeting HIF-1 for cancer therapy. Nature Rev. Cancer 3, 721–732 (2003).

  13. 13

    Lal, A. et al. Transcriptional response to hypoxia in human tumors. J. Natl Cancer Inst. 93, 1337–1343 (2001).

  14. 14

    Rosin-Arbesfeld, R., Cliffe, A., Brabletz, T. & Bienz, M. Nuclear export of the APC tumour suppressor controls β-catenin function in transcription. EMBO J. 22, 1101–1113 (2003).

  15. 15

    Jaakkola, P. et al. Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468–472 (2001).

  16. 16

    Mosimann, C., Hausmann, G. & Basler, K. Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with β-catenin/Armadillo. Cell 125, 327–341 (2006).

  17. 17

    Kaidi, A., Qualtrough, D., Williams, A. C. & Paraskeva, C. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res. 66, 6683–6691 (2006).

  18. 18

    van de Wetering, M. et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 4, 609–615 (2003).

  19. 19

    Zhong, H. et al. Overexpression of hypoxia-inducible factor 1 α in common human cancers and their metastases. Cancer Res. 59, 5830–5835 (1999).

  20. 20

    Vaupel, P., Thews, O., Kelleher, D. K. & Hoeckel, M. Current status of knowledge and critical issues in tumor oxygenation. Results from 25 years research in tumor pathophysiology. Adv. Exp. Med. Biol. 454, 591–602 (1998).

  21. 21

    Goethals, L. et al. Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers. Int. J Radiat. Oncol. Biol. Phys. 65, 246–254 (2006).

  22. 22

    Goda, N. et al. Hypoxia-inducible factor 1α is essential for cell cycle arrest during hypoxia. Mol. Cell Biol. 23, 359–369 (2003).

  23. 23

    Kim, J. H. et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes. Nature 434, 921–926 (2005).

  24. 24

    Essers, M. A. et al. Functional interaction between β-catenin and FOXO in oxidative stress signaling. Science 308, 1181–1184 (2005).

  25. 25

    Giles, R. H. et al. Interplay between VHL/HIF1α and Wnt/β-catenin pathways during colorectal tumorigenesis. Oncogene 25, 3065–3070 (2006).

  26. 26

    Iyer, N. V. et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 α. Genes Dev 12, 149–162 (1998).

  27. 27

    Maretto, S. et al. Mapping Wnt/β-catenin signaling during mouse development and in colorectal tumors. Proc. Natl Acad. Sci. USA 100, 3299–3304 (2003).

  28. 28

    Chell, S. D. et al. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence. Cancer Res. 66, 3106–3113 (2006).

  29. 29

    Elder, D. J., Hague, A., Hicks, D. J. & Paraskeva, C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines. Cancer Res. 56, 2273–2276 (1996).

  30. 30

    Essafi, A. et al. Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells. Oncogene 24, 2317–2329 (2005).

Download references

Acknowledgements

We would like to thank: P. Ratcliffe and C. Pugh for providing HIF-1α expression constructs, B. Vogelstein for providing β-catenin expression vectors, K. Basler and C. Mosimann for the β-catenin truncations, E. Fearon for the TCF-4DN expression vector, K. Malik for technical advice, K. Brown and B. Hassan for the critical reading of the manuscript. This work was funded by a scholarship from the Algerian Government, the Citrina foundation, and a programme grant from Cancer Research UK.

Author information

Correspondence to Christos Paraskeva.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information

Supplementary Figures S1, S2 and S3 (PDF 382 kb)

Rights and permissions

Reprints and Permissions

About this article

Further reading